Janux Therapeutics (JANX)'s 30-day implied volatility (IV30) was 101.7% at the close on November 3, 2026, up from 82.8% the day before, against a 52-week range of 34.8% to 194.8%. Its 20-day historical volatility was 53.7%.
Data as of November 3, 2026.